ArticleScientific reports2024

Montelukast, an available and safe anti-asthmatic drug, prevents maladaptive remodelling and maintains cardiac functionality following myocardial infarction.

Majeda Muluhie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.